GlassScriptPhysician profile
Brenna Shea Harris
NPI 1720259351
$1,926.31
in general payments reported to CMS, 2019-2025
22 companies · $349 in 2025
The $349 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $326 · 2023: $716 · 2024: $401 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.09 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.42 | 2021-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $315.62 | 2021-2025 | |
| Abbvie INC. | $215.63 | 2021-2023 | |
| Astellas Pharma US INC | $177.07 | 2023-2025 | Veozah, Myrbetriq |
| Antares Pharma, INC. | $172.65 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Shield Therapeutics INC | $107.93 | 2023-2025 | Accrufer |
| Exact Sciences Corporation | $96.72 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $84.83 | 2023-2025 | Aptima |
| Therapeuticsmd, INC. | $63.97 | 2021-2022 | |
| Lilly USA, LLC | $57.05 | 2024-2025 | Zepbound |
| Channel Medsystems, INC. | $49.41 | 2022 | |
| Verity Pharmaceuticals INC. | $36.35 | 2024 | Tlando |
| Halozyme INC | $34.92 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $28.02 | 2023 | Vivjoa |
| Scynexis, INC. | $19.81 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $16.61 | 2023 | Adthyza |
| Currax Pharmaceuticals LLC | $15.85 | 2025 | Contrave |
| Millicent US INC | $15.66 | 2025 | Femlyv |
| Coopersurgical, INC. | $15.05 | 2021 | |
| Exeltis, USA INC. | $14.27 | 2023 | Slynd |
| Aspira Women'S Health INC | $12.79 | 2021 | |
| Evofem Biosciences, INC. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenna Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.